Gentamicin Protection Assay

Gentamicin creates the assay’s extracellular selection step. Because the antibiotic generally does not penetrate intact eukaryotic cells effectively, bacteria outside the host cells are exposed to killing while bacteria located within cells are relatively protected. This differential exposure allows subsequent bacterial recovery to focus on the intracellular population.

Colony-forming units provide the assay’s quantitative readout. After host cells are lysed, recovered bacteria are plated, and the colonies that develop are counted as a measure of surviving bacteria present in the lysed sample. Comparing CFU values between experimental conditions helps evaluate differences in intracellular bacterial survival or treatment effects.

Bacterial recovery after gentamicin treatment represents organisms that remained associated with or protected by host cells during antibiotic exposure, rather than bacteria left outside the cells. By applying this treatment after cultured cells have encountered bacteria, investigators can examine cellular infection outcomes and assess how efficiently bacteria enter and survive in the host-cell environment.

A typical workflow includes exposing cultured host cells to bacteria, treating the culture with gentamicin to address extracellular organisms, washing the host cells, lysing them, and plating the released bacteria. The final colonies provide the measurable outcome, allowing researchers to quantify bacteria recovered from the host-cell sample after antibiotic treatment.

Each step prepares the sample for a different part of the measurement. Washing follows gentamicin exposure, lysis releases bacteria associated with the cultured host cells, and plating places the recovered organisms into a format where colony-forming units can be counted. Together, these steps connect antibiotic protection with a quantitative bacterial readout.

The assay supports comparisons involving host-cell responses, antimicrobial treatments, and bacterial mutations. Differences in recovered intracellular CFU can show whether a tested condition is associated with altered bacterial invasion or intracellular survival. In immunology and infection research, this connects bacterial behavior with the responses and interventions being studied in cultured host cells.